and photovitamin K deficiency induces prothrombin correction solution and quality control solution
Taiwan·Risk Class 2·FUJIFILM Wako Pure Chemical Corporation Mie Plant·Registered May 09, 2023 – May 09, 2028Active- Analysis ID
- bf6017b59775f034d34d2e1380f3502a
- Customs Code
- DHA05603617602
- Manufacturer Country
- Japan
- Authorized Representative
- MEDICARE PRODUCTS INC.
- Intended Use
- Calibration solution: used for the correction of photovitamin K deficiency-induced prothrombin (PIVKA II) test reagent. Quality control solution: quality control for the detection of photovitamin K deficiency-induced prothrombin (PIVKA II).
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 calibration;; A.1660 Quality control materials (analytical and non-analytical)
- Import Information
- Input;; QMS/QSD
- Registration Date
- May 09, 2023
- Expiry Date
- May 09, 2028
Access comprehensive regulatory information for and photovitamin K deficiency induces prothrombin correction solution and quality control solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number bf6017b59775f034d34d2e1380f3502a and manufactured by FUJIFILM Wako Pure Chemical Corporation Mie Plant. The authorized representative in Taiwan is MEDICARE PRODUCTS INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.